Skip to content

Study for the clinical efficacy and brain network mechanism of electroacupuncture in the treatment of mild and moderate depressive disorder

Study for the clinical efficacy and brain network mechanism of electroacupuncture in the treatment of mild and moderate depressive disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030291
Enrollment
Unknown
Registered
2020-02-27
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder

Interventions

Electroacupuncture group:electroacupuncture
Placebo group:Sham electroacupuncture

Sponsors

Guangdong Province Traditional Chinese Medical Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria of Depressive Disorder Due to Another Medical Condition according to DSM – 5 from the American psychiatric association,and the level of depression conforms to moderate to mild depression (F32.0) or moderate depression (F32.1) according to the International Classification of Diseases Coding Table (ICD-10) or whose HAMD-17 score 8-22; 2. Participants was diagnosed with a first appearance depressive disorder; 3. Aged 18 to 40 years; 4. Have not received medications for depression medication within 3 months prior to enrollment in the study; 5. A signed informed consent form specific for this trial.

Exclusion criteria

Exclusion criteria: 1. Item 4 or 5 of Beck Suicide Ideation Scale (SSI) is not answered "No"; 2. The depression factors in SCL-90 score failed to exclude the suicidal tendency (>26); 3. Participants had participated in other clinical trials within 4 weeks before the start of this study; 4. Participants who had severe diseases of other systems require treatment; 5. Participants had brain diseases and judgment ability was abnormal (Wechsler Adult Intelligence Scale< 90); 6. Women who are/be intended pregnancy or breastfeeding; 7. Participant who install a pacemaker or an artificial joint.

Design outcomes

Primary

MeasureTime frame
HAMD-17;Electroencephalogram;

Countries

China

Contacts

Public ContactWu Qian

Guangdong Province Traditional Chinese Medical Hospital

wuqian@vip.163.com+86 13580323354

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026